Dr. Angelina Postoev Sounds the Alarm on New Barriers to Life-Saving GLP-1 Medications
Obesity is one of the most pressing health challenges facing Americans today. For many, GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro have offered hope—a path toward sustainable weight loss, improved health, and renewed confidence. But now, that hope is being ripped away by new legislation, regulatory crackdowns, and soaring prices.
Dr. Angelina Postoev, a triple board-certified surgeon and fierce advocate for equitable healthcare, is raising awareness about the growing inaccessibility of these medications—and the people being left behind.
As demand skyrockets, the gap between those who can afford these drugs and those who can’t has never been wider.For patients unable to access the brand-name medications, compounded versions—prepared by specialized pharmacies using active ingredients like tirzepatide (the key ingredient in Mounjaro)—have served as a more affordable, although unregulated, alternative.
But on March 19, 2025, the FDA officially removed compounded GLP-1 medications from the market, citing safety concerns. And with new legislation poised to take effect soon, costs will rise and access will tighten even further—especially for those without high-tier insurance plans. Meanwhile, pharmaceutical companies like Eli Lilly and Company continue to state there’s “no shortage” of medications like Mounjaro—yet patients and providers are experiencing a much different reality. We’re seeing firsthand that access is declining, options are disappearing, and patients are desperate. This is a public health crisis rooted in profit—not care.
Dr. Angelina is urging Americans to understand the difference between brand-name GLP-1s and compounded alternatives—and why removing one option without addressing affordability of the other is a dangerous misstep. This fight isn’t about vanity—it’s about health, mobility, and quality of life. Obesity affects everything from heart health to joint pain to mental well-being. It is not a trend or cosmetic concern—it’s a condition that deserves real solutions.